NSGC Information Technology Co., Ltd. (NSGC Technology) is both a cybersecurity enterprise engaged in technological innovation and a software firm focusing on cyber range construction and cybersecurity talent cultivation. It boasts a long history of doing business with the military industry, and it has produced a wide range of competitive cyber range products. At its inception in 2014, NSGC Technology initiated XCTF, a CTF (capture the flag) competition ranking first in Asia and second in the world, which earned the company a strong international reputation. NSGC Technology started to tap the global market in 2017 and has fostered an international outlook over many years of overseas practices. Its products and services are now available in more than twenty countries. While competing with leading global manufacturers, it has developed insights into the cyber range sector and become the only internationally competitive Chinese enterprise in this field. However, as the company marched from the military industry into non-military fields, it became trapped in low-level industry competition in 2021. In addition, the company’s overseas business has been severely impacted since 2020 by the COVID-19 outbreak. At the beginning of 2022, facing challenges at home and abroad, NSGC Technology had to carefully examine the relationship between domestic and global markets and formulate a new corporate development strategy.
As of the end of 2019, the point-of-care testing (POCT) products of Getein Biotech Inc., an important in vitro diagnostics (IVD) enterprise, had been successfully applied to the detection of many diseases, including cardiovascular diseases, inflammation, kidney diseases, and blood coagulation disorders. Its market share and output value were both among the highest in the industry. In addition to improving its core POCT products, Getein Biotech firmly grasped industry opportunities to accelerate expansion in key IVD segments and build a complete product system. However, with the impact of COVID-19 in 2020, the enterprise, unlike its competitors in this industry, failed to seize the opportunity of developing COVID-19 test kits. As a result, its profits fell sharply, and its competitive position in the industry faced huge challenges. At the beginning of 2021, due to uncertainties about the COVID-19 pandemic, the enterprise was forced to integrate its original resources and capabilities and adjust its development strategy in order to establish sustainable competitive advantages.